Invasive bilateral breast cancer and high grade serous ovarian cancer with BRCA1-germline mutation and brainstem metastasis under PARP inhibitors

For breast cancer patients, BRCA gene mutations are predictive of a good response to chemotherapy, but are hampered by a high risk of bilateral and synchronous or metachronous ovarian cancer. Novel therapies such as PARP-inhibitors have proven effective for BRCA1/2 mutated ovarian cancer. We present...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahari, Mihaela Mărioara, Chiorean, Angelica Rita, Duma, Maria Magdalena, Ungureanu, Andrei, Kacso, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: UMF “Gr. T. Popa” Iasi Publishing House 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565681/
https://www.ncbi.nlm.nih.gov/pubmed/34754911
http://dx.doi.org/10.22551/2019.24.0603.10156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565681/
https://www.ncbi.nlm.nih.gov/pubmed/34754911
http://dx.doi.org/10.22551/2019.24.0603.10156

Ejemplares similares